Dr. Sue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2946 E Banner Gateway Dr
Gilbert, AZ 85234Phone+1 480-256-6444Fax+1 480-256-3682
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
University of WashingtonResidency, Internal Medicine, 1994 - 1997
University of California San Francisco School of MedicineClass of 1994
Certifications & Licensure
AZ State Medical License 2004 - 2027
NE State Medical License 2018 - 2026
WA State Medical License 1996 - 2026
CA State Medical License 2018 - 2025
CO State Medical License 2018 - 2025
GA State Medical License 2020 - 2025
NV State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Most Compassionate Doctor American Registry
Clinical Trials
- Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study) Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 1 citationsOptimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves.T David Koster, Pallav L Shah, Arschang Valipour, Gerard J Criner, Felix J F Herth
Respiratory Medicine. 2024-06-01 - 16 citationsEffect of zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year: Results from a randomized clinical trialMark T. Dransfield, Justin L. Garner, Surya P. Bhatt, Dirk-Jan Slebos, Karin Klooster
Annals of the American Thoracic Society. 2020-03-30 - Reply to Fitzmaurice et al. : The LIBERATE Trial: Options to Reduce the Risk of Post-procedural Pneumothorax and Length of Stay.Gerard J. Criner, Richard Sue, Frank C. Sciurba, Dirk-Jan Slebos
American Journal of Respiratory and Critical Care Medicine. 2018-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
